University of Pittsburgh Medical Center data showed risk-adjusted mortality, successful discharge and ICU admissions were only slightly different after adhering to the federally required SEP-1 treatment protocol for sepsis, compared with what would have been expected without the mandate. The study, reported in the Annals of Internal Medicine, found that throughout the 11-hospital system, ICU admission was 22.4% after the protocols were implemented, compared with a 20.4% expected rate.
The number of new COVID-19 cases in the US fell by 0.4% for the week ending April 18, following four consecutive weeks of increase, but the country still logged almost 70,000 new cases per day last week as variants continue to spread. The average number of patients hospitalized with COVID-19 climbed by 5% to over 41,000, marking the third straight weeks of increase, while related fatalities dropped 2.8%.
Shifting wound care experience during COVID-19 For most patients, wound care is a very personal and novel experience and a patient's connection to their doctor as their wound is treated is sometimes as important as the treatment itself. Patients have questions and concerns that need a personal touch as they engage in their healing journey. Care for wound patients rapidly shifted in the spring of 2020. Enter the 3M home support.
The CDC could decide by Friday if restrictions will be added to the Johnson & Johnson vaccine after six women reported blood clotting issues after receiving the shot, according to National Institute of Allergy and Infectious Diseases Director Anthony Fauci. The US paused use of J&J's vaccines last week.
All US individuals ages 16 and older can now receive a COVID-19 vaccine, according to the CDC, which said those with underlying medical conditions that raise the risk for serious complications should be given priority. Nearly 211.6 million COVID-19 vaccine doses had been administered in the US as of Monday, with more than 85.3 million people now fully vaccinated.
The US will allocate $1.7 billion to facilitate detection, monitoring and mitigation of emerging and potentially more infectious coronavirus variants, according to the Biden administration. About half of current US cases involve variant forms of the virus, a figure that "underscores the critical need for rapid and ongoing genomic surveillance," said CDC Director Rochelle Walensky.
A skin sweat sensor that can continuously measure cytokine levels for approximately 168 hours has been developed by researchers from Texas startup EnLiSense and the University of Texas. The device has been modified and can be used to monitor COVID-19 patients.